Investigator Details
Christopher R Czajka
Investigation Details
Last Issued Date
April 2, 2024
No. of 483’s Issued
since 2023
18
Warning Letters Issued
1
Detailed Analysis
Approach:
Christopher R Czajka focuses on meticulously assessing the cleanliness and aseptic conditions in production areas. He also places high importance on laboratory testing and containment procedures to ensure the quality and safety of drug products.
Profile:
Christopher R Czajka tends to focus on aseptic processing areas, containment procedures, cleanliness, and laboratory testing. He prioritizes ensuring the proper procedures for aseptic production and conformance testing to maintain the quality of drug products.
Top Process Types:
- Contamination Control
- Facility Design
- Cleaning Validation
- Batch Release
- Material Sampling and Testing
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now